Patent assignee · US · COMPANY

Edison Pharmaceuticals, Inc.

28Patents
25Active
28Granted
48Portfolio score

Filing activity: Oct 29, 2003 → Sep 10, 2015 · 8 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7470798B2 7,8-bicycloalkyl-chroman derivatives Chemistry; Metallurgy 49 Expired
US7432305B2 Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Chemistry; Metallurgy 48 Active
US8314153B2 Treatment of pervasive developmental disorders with redox-active therapeutics Chemistry; Metallurgy 47 Active
US7514461B2 Chroman derivatives Chemistry; Metallurgy 46 Expired
US7491312B2 Identifying therapeutic compounds based on their physical-chemical properties Physics 43 Expired
US8106223B2 Process for the production of alpha-tocotrienol and derivatives Chemistry; Metallurgy 41 Active
US7968746B2 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Chemistry; Metallurgy 41 Active
US8716486B2 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases Chemistry; Metallurgy 36 Active
US8716527B2 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Chemistry; Metallurgy 35 Active
US8575369B2 Process for the production of alpha-tocotrienol and derivatives Chemistry; Metallurgy 33 Active
US8653144B2 Treatment of pervasive developmental disorders with redox-active therapeutics Chemistry; Metallurgy 31 Active
US8519001B2 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Chemistry; Metallurgy 27 Active
US8791155B2 Chroman derivatives Chemistry; Metallurgy 19 Active
US9162957B2 Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols Chemistry; Metallurgy 19 Active
US9278085B2 Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Chemistry; Metallurgy 19 Active
US9370496B2 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones Human Necessities 19 Active
US8952071B2 (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases Chemistry; Metallurgy 18 Active
US9296712B2 Resorufin derivatives for treatment of oxidative stress disorders Chemistry; Metallurgy 12 Active
US9399612B2 Treatment of pervasive developmental disorders with redox-active therapeutics Chemistry; Metallurgy 10 Active
US9169196B2 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Chemistry; Metallurgy 10 Active
US8969420B2 Treatment of pervasive developmental disorders with redox-active therapeutics Chemistry; Metallurgy 8 Active
US9447006B2 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Chemistry; Metallurgy 7 Active
US9486435B2 (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases Chemistry; Metallurgy 7 Active
US9073873B2 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases Chemistry; Metallurgy 4 Active
US9090576B2 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Chemistry; Metallurgy 3 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.